Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis

55Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nineteen adults with pulmonary tuberculosis received linezolid (600 mg) once or twice daily in an early bactericidal activity trial. A one-compartment population model produced median values for the absorption rate constant, volume of distribution, and elimination rate constant of 1.5 h-1, 29.6 liters, and 0.25 h-1 (once daily) and 2.7 h-1, 32.1 liters, and 0.15 h-1 (twice daily). Linezolid administered twice daily produced higher values for free drug area under the concentration-time curve (AUC)/MIC and time above MIC. Both regimens achieved free AUC/MIC ratios > 100. Median times above the MIC for free drug were 100% (twice daily) and 63% (once daily). Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

McGee, B., Dietze, R., Hadad, D. J., Molino, L. P. D., Maciel, E. L. N., Boom, W. H., … Peloquin, C. A. (2009). Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis. Antimicrobial Agents and Chemotherapy, 53(9), 3981–3984. https://doi.org/10.1128/AAC.01378-08

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free